Improving Treatment for Severe Acute Neonatal Hyperammonemia Using a Personalized Algorithm

What this Trial Is About

This research focuses on acute neonatal hyperammonemia, a serious condition linked to poor neurological outcomes and high mortality in newborns. Researchers aim to validate a user-friendly, widely applicable algorithm that tailors treatment based on kinetic modeling. This approach is designed to help medical staff personalize care for babies with severe hyperammonemia by predicting treatment times and dialysis settings specific to each patient. The study evaluates an algorithm that uses a simple spreadsheet to calculate dialysis protocols. It considers factors like patient body weight, blood flow rate, and ammonia concentration to tailor treatment. The algorithm is based on measurements of ammonia levels before and after dialysis, allowing precise calculation of dialyzer clearance and treatment duration. This method aims to improve the management of acute neonatal hyperammonemia with practical, individualized guidance. Participants under one year old with severe neonatal hyperammonemia undergoing acute hemodialysis will be involved. The study will monitor serum ammonium levels over one year as the primary outcome, along with the removal of sodium benzoate and L-arginine as secondary outcomes. Data collection includes ammonia measurements during dialysis sessions to assess the algorithms accuracy and effectiveness in guiding treatment plans.

Optimalisation of the Treatment of Acute Neonatal Hyperammonaemia